Ellen Kuhl named director of Stanford Bio-X
March 29, 2024 - Stanford News
Kuhl aims to continue Bio-X’s legacy of facilitating multidisciplinary fundamental research and innovation.
Stanford Bio-X affiliated faculty members and fellows are generating scientific advances that expand our understanding of how the body works and will ultimately improve human health. These news stories and press releases describe some of those breakthroughs.
-
Apply for the 2015 Stanford Bio-X Graduate Student Fellowships!
January 9, 2015
The Stanford Bio-X Leadership Council is pleased to announce the 12th annual competition for Stanford Bio-X Graduate Student Fellowships -
Stanford researchers measure concussion forces in greatest detail yet
January 6, 2015 - Stanford Report
Bio-X affiliated faculty member, 2004 Bio-X Bowes Fellow, and 2012 IIP Seed Grant awardee David Camarillo and 2013 Bio-X Honorary Fellow Fidel Hernandez have measured the forces imparted on the brain in greater detail than ever before. -
New version of common antibiotic could eliminate risk of hearing loss
January 2, 2015 - Stanford Medicine News Center
Under Bio-X affiliated faculty members Anthony Ricci, Alan Cheng, Daria Mochly-Rosen, and Michael Hsieh, a study in mice has found that a commonly used antibiotic can be modified to eliminate the risk that it will cause hearing loss. -
Newly identified molecular network in brain implicated in autism, researchers say
December 30, 2014 - Stanford Medicine News Center
Some cases of autism may be caused by a dysfunctional corpus callosum, resulting in poor communication between brain hemispheres, a new study suggests. -
Skin patch could help heal, prevent diabetic ulcers, study finds
December 22, 2014 - Stanford Medicine News Center
Researchers under Bio-X affiliated faculty member Geoffrey Gurtner knew that a drug administered to remove iron from the blood could also overcome diabetic interference with blood vessel formation, but finding the right way to deliver it was the challenge. -
Stanford chemists take step toward solving mystery of how enzymes work
December 19, 2014 - Stanford Report
Research by Bio-X affiliated faculty member Steven Boxer and 2012 Bio-X SIGF Fellow Stephen Fried, has found that the electrostatic field within an enzyme accounts for the lion's share of its success. -
Stem cells faulty in Duchenne muscular dystrophy, researchers find
December 17, 2014 - Stanford Medicine News Center
In a mouse model of Duchenne muscular dystrophy, muscle stem cells express connective-tissue genes associated with fibrosis and muscle weakness, according to a new study under Bio-X affiliated faculty member Thomas Rando. -
Poor semen quality linked to hypertension, other health problems
December 10, 2014 - Stanford Medicine News Center
A new study, under Bio-X affiliated faculty members Michael Eisenberg, Mark Cullen, and Barry Behr, of men who were evaluated for the cause of their infertility finds relationships between deficiencies in their semen and other health problems. -
Stanford engineers take big step toward using light instead of wires inside computers
December 2, 2014 - Stanford Report
Using a new algorithm, engineers under Bio-X affiliated faculty Jelena Vuckovic can design and build a prism-like silicon structure that can bend light at right angles. -
An enzyme that fixes broken DNA sometimes destroys it instead, researchers find
November 26, 2014 - Stanford Medicine News Center
The discovery of a new mechanism of DNA damage under Bio-X affiliated faculty Karlene Cimprich could offer insights into cancer and neurodegenerative disease. -
Blistering skin disease may be treatable with ‘therapeutic reprogramming’
November 26, 2014 - Stanford Medicine News Center
Researchers under Bio-X affiliated faculty members Anthony Oro, Marius Wernig, and Mark Kay were able to correct a collagen defect — the source of a blistering skin disease — in stem cells made from patients. -
Stanford scientists seek to map origins of mental illness and develop noninvasive treatment
November 25, 2014 - Stanford Report
A team under Bio-X affiliated faculty Amit Etkin and Stephen Baccus has convened to map the origins of mental illnesses in the brain and develop noninvasive treatments. -
Stanford engineers climb walls using gecko-inspired climbing device
November 21, 2014 - Stanford Report
Stanford engineers under Bio-X affiliated faculty member Mark Cutkosky have designed a controllable adhesive system that can stick to glass and support a person's weight. -
A brain-imaging discovery resolves a century-old argument
November 20, 2014 - Stanford Report
A team under Bio-X affiliated faculty Brian Wandell and Kalanit Grill-Spector, including Bio-X Travel Awardee Jason Yeatman, rediscovered a disputed brain pathway in the basement of Lane Medical Library. -
Pluripotent cells created by nuclear transfer can prompt immune reaction
November 20, 2014 - Stanford Medicine News Center
Stanford researchers including Bio-X affiliated faculty Irving Weissman find that genetic differences in mitochondria contained in egg cells used in a process known as nuclear transfer can prompt rejection by the immune system in mice. -
Of mice and men: Researchers compare mammals’ genomes to aid human clinical research
November 19, 2014 - Stanford Medicine News Center
Research by Bio-X affiliated faculty Michael Snyder comparing human and mouse genomes reveals both shared principles and differences in how genes are regulated. -
Stanford team creates computer vision algorithm that can describe photos
November 18, 2014 - Stanford Report
Research by Bio-X affiliated faculty Fei-Fei Li has taken computer vision to the next level with a system that can describe objects and put them into context. -
Stanford team creates computer vision algorithm that can describe photos
November 18, 2014 - Stanford Report
Computers only recently began to get the software needed to discern unknown objects; now, research by Bio-X affiliated faculty Fei-Fei Li takes machine-learning to the next level with a system that can describe objects and put them into context. -
Chemists develop 'nanoreactor' for discovering new chemical reactions
November 17, 2014 - Stanford Report
Research by Bio-X affiliated faculty members Todd Martinez and Vijay Pande involves a new computer model to identify unknown chemical mechanisms that could improve energy production and storage, or the development of new medicines. -
‘Big data’ approach helps pinpoint possible new stent drug to prevent heart attacks
November 17, 2014 - Stanford Medicine News Center
Bio-X affiliated faculty Euan Ashley, Vinicio de Jesus Perez, and Thomas Quertermous say that replacing the current drug used to coat artery-opening stents with a more targeted one could reduce blood clots and heart attacks. -
Tumor suppressor also inhibits key property of stem cells, researchers say
November 13, 2014 - Stanford Medicine News Center
Researchers under Bio-X affiliated faculty Julien Sage, Marius Wernig, Steven Artandi, and Anne Brunet have shown that retinoblastoma protein binds to and inhibits genes necessary for stem cell pluripotency. -
Retinal-scan analysis can predict advance of macular degeneration
November 5, 2014 - Stanford Medicine News Center
Partially supported by a Bio-X IIP Seed Grant, a new computer algorithm designed by Bio-X affiliates Daniel Rubin and Rob Tibshirani could help physicians predict whether a patient’s macular degeneration will progress within a year’s time. -
Oxytocin levels in blood, cerebrospinal fluid are linked, study finds
November 4, 2014 - Stanford Medicine News Center
A new study partly supported by Bio-X/Bio-X NeuroVentures Program, by affiliated faculty Karen Parker, Joseph Garner, Samuel Cheshier, Sonia Partap, and Antonio Hardan and Bio-X Undergraduate Fellow Tara Trujillo, shows that oxytocin levels in blood are correlated to levels in cerebrospinal fluid. -
Stanford engineers discover how to record the forensic history of chemical contaminations in water
November 3, 2014 - Stanford Report
Bio-X affiliated faculty Sindy Tang has invented a time capsule, a tiny chemistry lab designed to take a fingerprint of contamination and also disclose when it occurred. -
New molecular imaging technology could improve bladder-cancer detection, researchers say
October 29, 2014 - Stanford Medicine News Center
Researchers under Bio-X affiliates Joseph Liao, Irv Weissman, Matt van de Rijn, and Sam Gambhir have developed a new imaging method that targets a protein known as CD47 in human bladder cancer. -
New way of genome editing could cure hemophilia in mice; may be safer than older method, study shows
October 29, 2014 - Stanford Medicine News Center
A technique developed under Bio-X affiliated faculty members Mark Kay and Matthew Porteus could provide an improved method of replacing faulty, disease-causing genes. -
Study finds brain abnormalities in chronic fatigue patients
October 28, 2014 - Stanford Medicine News Center
Radiology researchers under Bio-X affiliated faculty members Michael Zeineh and Allan Reiss have discovered that the brains of patients with chronic fatigue syndrome have diminished white matter and white matter abnormalities in the right hemisphere. -
Group classes teach parents effective autism therapy, study finds
October 27, 2014 - Stanford Medicine News Center
A new study under Bio-X affiliated faculty member Antonio Hardan has found that parents who learned an autism therapy in group classes helped their children with the disorder improve their language skills. -
Stem cells' rapid response due to short-lived RNA messages
October 16, 2014 - Stanford Medicine News Center
Stem cells stay developmentally nimble by actively targeting key RNA messages for destruction. Bio-X affiliated faculty members Howard Chang and Marius Wernig say this 'anti-epigenetics' works to ensure the transience of genetic information. -
Decoy drug allows brains of adult mice to form new connections
October 15, 2014 - Stanford Report
A team of scientists under Dr. Carla Shatz, the director of Stanford Bio-X, has restored the ability of adult mice to form new connections in the brain. If the finding works in people, it has the potential to help adults recover from stroke and forms of blindness or to prevent the loss of connections in Alzheimer's disease.